window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

AI in drug development

  • Artificial Intelligence,Clinical Development,Clinical Trials,Technology and platforms

    Evinova and Bristol Myers Squibb collaborate on AI-driven clinical trial optimisation

    Evinova and Bristol Myers Squibb have entered a strategic collaboration [...]

    February 9, 2026
  • Biotech,Drug Development,Partnerships & Funding,Rare Diseases,Technology and platforms

    Mendra launches with $82 million Series A to develop rare disease therapies

    Mendra, Inc. has launched with the closing of an $82 [...]

    January 23, 2026
  • Artificial Intelligence,Biologics & Biosimilars,Cell & Gene Therapy,Clinical Development,Drug Development,Movers & Shakers,Pharmaceuticals and therapeutics

    Formation Bio expands leadership team with biotech and pharma veterans to accelerate AI-driven drug development

    Formation Bio, the AI-native pharmaceutical company advancing a new model [...]

    September 23, 2025
  • CDMOs & Manufacturing,Drug Development,Market Access & Commercialization,Partnerships & Funding,Supply Chain & Logistics,Technology and platforms,Women in Pharma

    CPHI Frankfurt’s puts spotlight on innovation, partnerships and sustainability – an interview with event director, Tara Dougal

    As CPHI Frankfurt 2025 prepares to welcome more than 60,000 [...]

    September 11, 2025
  • CDMOs & Manufacturing,Drug Development,Market Access & Commercialization,Partnerships & Funding,Supply Chain & Logistics,Technology and platforms,Uncategorised

    CPHI Frankfurt 2025 set to welcome more than 60,000 global pharma professionals

    CPHI Frankfurt 2025 will bring the world’s pharmaceutical community back [...]

    September 11, 2025
  • Artificial Intelligence,Clinical Trials,Drug Development,Real world evidence,Research & Development

    QuantHealth clinical trial simulations deliver $31.4m savings and 90% accuracy

    QuantHealth has simulated more than 350 clinical trials using its [...]

    July 23, 2025
  • Biologics & Biosimilars,Clinical Development,Drug Delivery & Formulation,Global health,Partnerships & Funding,Rare Diseases

    New research partnership targets $1 malaria prevention shot using next-gen biologics

    Eyam Health, a Canadian biotech, teams with Medicines for Malaria [...]

    July 22, 2025
  • Artificial Intelligence,Clinical Development,Clinical Trials,Drug Development,Rare Diseases

    AI validation of rentosertib efficacy supports global trial expansion in IPF

    Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]

    July 16, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Cell & Gene Therapy,Drug Development,Technology and platforms

    Elegen and Nutcracker pilot cell-free RNA manufacturing for personalized cancer therapeutics

    Collaboration targets faster, lower-cost production of RNA-based therapies with reduced [...]

    July 15, 2025
  • Cell & Gene Therapy,Partnerships & Funding,Technology and platforms

    Broken String and BioLizard partner on AI tool to improve gene editing safety

    Eurostars-3 grant supports development of SafeGuide to reduce time and [...]

    July 14, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top